Please assess the completion status of the following clinical trial:

Trial Title: Analgesia iv vs Epidural Analgesia vs Port-sites Infiltration After Laparoscopic Sleeve Gastrectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* body mass index (BMI) \>40 Kg/m2~* BMI \> 35 Kg/m2 with the presence of comorbidities associated to obesity~Exclusion Criteria:~* patients undergoing other bariatric techniques~* severe underlying cardiovascular diseases~* chronic renal failure~* hepatic dysfunction~* previous foregut surgery~* patients with any contraindication for bariatric surgery

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Port-sites infiltration:Bupivacaine0,25% (Type: EXPERIMENTAL): Port-sites infiltration will be performed with 10 ml of Bupivacaine 0.25%, applying 2 ml under the aponeurotic layer in each port. Associated intravenous analgesia will include Metamizole 2g/8h and Acetaminophen 1g/8h, alternating every 4 hours.
- Epidural analgesia:Levobupivacaine0.125% (Type: EXPERIMENTAL): Epidural analgesia consists in the placement of a thoracic epidural catheter inserted at the level T6-T7 and administration of a continuous perfusion of Levobupivacaine 0.125% 6ml/h.~Associated intravenous analgesia will include Metamizole 2g/8h and Acetaminophen 1g/8h, alternating every 4 hours.
- Metamizole and Acetaminophen iv (Type: ACTIVE_COMPARATOR): Associated intravenous analgesia will include Metamizole 2g/8h and Acetaminophen 1g/8h, alternating every 4 hours.

Based on this trial design, predict the completion outcome and termination type (if applicable).